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ORIGINAL ARTICLE
Mammography is the standard imaging modality
for breast cancer screening and regular mammo-
graphic surveillance is recommended for high-
risk women and the general population over 
40 years of age.1,2 However, mammography would
not appear to be an effective screening test for
women younger than 40 years of age for four 
relevant reasons. First, the relative sensitivity of
mammography for detecting breast cancer can
be somewhat reduced for dense breasts, which
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often occur among younger women.3–5 Second,
mammographic surveillance with clinical breast
examination among younger women would ap-
pear to feature a relatively low accuracy for detect-
ing breast cancers, especially in carriers of a BRCA
gene mutation. The possible reasons for such an
outcome include a greater rate of growth of tu-
mors among such women, the presence of atypi-
cal findings seen on mammograms and specific
histopathologic characteristics in carriers of BRCA
mutations.6 Third, the breast tissue in younger
women tends to feature increased radiation sen-
sitivity, which encourages attending clinicians and
radiologists against the use of mammography.
Fourth, the incidence of breast cancer among
younger women is relatively lower than in their
older counterparts.4 Nowadays, mammography
would appear to be often used for symptomatic
women younger than 40 years old. However, some
published papers documented the low diagnos-
tic yield of mammography for young women
with symptoms, especially if they presented with
a palpable mass.7,8 On the other hand, a number of
other studies have reported that mammography
is a promising diagnostic tool for young women
suffering from breast cancers.4,5 However, the
aforementioned series focused on the studies of
younger-aged women in Western countries. On
the other hand, the breasts of Asian women are
usually smaller and denser than those of their
Western counterparts.9 In our country, it was re-
ported that false-negative (FN) cancers on mam-
mograms occurred more often in denser breasts
(heterogeneous or extremely dense breasts), com-
pared to true-positive (TP) cancers on mammo-
grams.9 However, the research was on women of
all age groups with breast cancer, not only on
younger-aged women (< 40 years). Actually, there
is a higher percentage of younger-aged women
with dense breast parenchymal pattern compared
with their older counterparts.5 Herein, we present
the mammographic findings for a large series of
women with breast cancer at our institute, all of
whom were aged less than 40 years at the time 
of diagnosis. Further, we also attempted to estimate
the relative diagnostic accuracy of mammography
for breast cancer, and the overall role of mammo-
graphy in the diagnosis of younger-aged women
afflicted by breast cancer in Taiwan.
Materials and Methods
Patient collection
From a retrospective review of the chart records
of our hospital, a total of 1766 women were di-
agnosed with breast cancer between April 1999
and June 2005 and underwent definitive surgery
in our institution. Of these, 227 women (12.9%)
were diagnosed before 40 years of age. Of the 227
women, 44 underwent mammograms after exci-
sional biopsy for the cancer but before definitive
surgery, 36 patients received only breast ultra-
sound examinations before surgery, and 42 pa-
tients were referred from outside institutes so
their preoperative mammograms were not avail-
able, thus leaving 105 patients who had their
pre-biopsy mammograms performed in our hos-
pital and which were available for analysis. Of
the 105 patients, 90 received corresponding pre-
biopsy breast ultrasound in our hospital with the
results available for correlation; all of these ultra-
sonographic examinations were performed by ex-
perienced, fixed sonographic technicians under
the supervision of breast surgeons or radiologists
using HDI® 3000 or 5000 Ultrasound Systems
(ATL Ultrasound, Bothell, WA, USA), and the clin-
ical information of the patients were all available
during the examinations.
The retrieval of the patients’ medical records
was approved by the institutional review board
of our hospital. The patient lists during the study
period were obtained from the Department of
Cancer Registry, Office of Medical Records of our
hospital.
Mammographic interpretation, analysis and
correlation with breast ultrasound and
histopathology
We used a dedicated mammographic unit (GE,
Senographe DMR, Buc, Cedex, France) with 18 ×
24 cm Min-R M or Min-R 2000 screen/film systems
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(Eastman Kodak, Rochester, NY, USA) for the
participants. The processing time was 90 seconds
for each exposure. All mammograms were per-
formed by fixed and qualified radiologic techni-
cians in our department, and additional imaging
workup such as spot compression views or spot
magnification views with skin BB marker label-
ing were routinely performed for patients with
clinically suspicious, palpable findings. The pre-
biopsy mammograms of the 105 patients were
read prospectively by on-site mammographers
(first reading, with clinical information available
for interpretation based on the questionnaires
filled out by the patients) and retrospectively by a
radiologist who had extensive experience in mam-
mography (second reading, with all diagnostic
mammographic views and final diagnoses avail-
able for interpretation). The breast composition
for each patient, as revealed by mammograms, was
estimated according to the ACR (American College
of Radiology) lexicon, that is, ACR 1 represents “the
breast is almost entirely fat”, ACR 2 corresponds
to “there are scattered fibroglandular tissues”,
ACR 3 represents “the breast is heterogeneously
dense”, and ACR 4 is “the breast is extremely
dense”. Tumor size, predominant mammographic
manifestations of breast cancers present and their
corresponding breast ultrasonographic findings
prior to biopsy were analyzed and compared with
the corresponding histopathologic findings for
study participants. The histology types and grades
of the cancers were also recorded. The second
reading of the pre-biopsy mammograms was also
compared with the first reading prior to biopsy.
Further, the distribution of different breast com-
positions between TP and FN lesions at the first
and second mammographic readings were also
categorized and estimated.
The mammographic assessment was catego-
rized as: TP, if the cancers could be recognized on
imaging as BI-RADS® (Breast Imaging Reporting
and Data System) category 0 (mammographic as-
sessment is incomplete, need additional imaging
evaluation), BI-RADS® category 4 (suspicious find-
ing, biopsy is recommended), or BI-RADS® cate-
gory 5 (highly suggestive of malignancy), according
to ACR BI-RADS® either on the first or second
reading. A FN result was defined as: a cancer that
could not be identified and was interpreted as
normal (BI-RADS® category 1) or benign (BI-
RADS® category 2) or probably benign (BI-RADS®
category 3) on imaging, either on the first or second
reading.
Statistical analysis
The mean size of mammographic TP lesions at
the first and second readings were compared with
corresponding histopathologic results using paired
Student’s t test. The mean pathologic size of the
mammographic TP and FN lesions at the first and
second readings was compared using Wilcoxon
rank sum test. The distribution of breast compo-
sition between mammographic TP and FN lesions
at the first and second readings was tested using
Fisher’s exact test. A p value < 0.05 was considered
to be statistically significant.
Results
During the period of patient enrolment, a total
of 109 pathologically proven breast-cancerous 
lesions from 105 patients were diagnosed. The
ages of the 105 patients ranged from 26 to 39
years (mean, 34.93±3.48 years; median, 35 years).
Seven (6.7%) of them had their breast cancers
diagnosed before 30 years of age. Only one of the
105 patients was asymptomatic, and this patient
had a cancer revealing clustered microcalcifica-
tions on mammography, which was nonpalpable.
The reason why she presented for mammogra-
phy was to receive a routine follow-up after an
excisional biopsy for a benign fibroadenoma in a
different quadrant of the breast. The other 104 pa-
tients featured clinically relevant palpable masses,
with the duration of patient-experienced symp-
toms ranging from 7 days to 10 years (mean, 8.44
months; median, 2 months), with all the palpable
lumps corresponding to the cancerous lesions.
Twenty-one of the 105 patients (20%) experienced
symptoms for a period longer than 12 months,
and 14 of 105 (13.3%) suffered from symptoms
J. Wang, et al
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lasting longer than 24 months—they presented
to a medical clinic due to recent enlargement of
their pre-existing masses. Of the 105 patients, 24
(22.8%) were nulliparous and one (1.0%) was
pregnant at the time of their cancer diagnosis.
Nine of 105 patients (8.6%) revealed a family
history of breast cancer. Twenty-four of 105 
patients (22.8%) had given birth to their first
baby before 30 years of age, and only one of
these 24 patients (4.2%) had a family history of
breast cancer.
Of the 109 pathologically proven cancerous
lesions, 92 lesions were detected on mammogra-
phy by on-site radiologists (first reading), featur-
ing a sensitivity of 84.4% and a FN rate of 15.6%.
Further, seven additional cancers (a total of 99
cancerous lesions) were detected at the second
mammographic reading, featuring a sensitivity of
90.8%, and a FN rate of 9.2%. Of the 17 FN lesions
missed by the first mammographic reading, 13 of
17 cancers were unifocal solitary findings from
different patients, with all of the 13 lesions rec-
ognized by ultrasound. Breast ultrasound detected
a total of three additional multifocal cancers in two
patients. One patient had a FN lesion lying in close
proximity to the major TP cancer, the two lesions
were considered to be in the same palpable area
according to the chart record, and ultrasound de-
tected both lesions. Another patient had three FN
satellite lesions that were again located very close
to a major TP cancer, and all four lesions corre-
sponded to the same palpable region. The corre-
sponding ultrasound of this patient detected two
of the three satellite cancers compared to the first
mammographic finding. The FN satellite lesions
of the two aforementioned patients were again
missed at the second mammographic reading.
Of the seven women who had had their breast
cancers diagnosed before 30 years of age, one
featured a solitary cancerous focus that could not
be detected either at the first or second mammo-
graphic reading (one FN lesion, Figure 1).
The dominant mammographic findings for
the 92 TP lesions detected at the first mammo-
graphic reading and those for the 99 TP lesions
revealed at the second reading are summarized
in Table 1. Of the 92 TP lesions detected at the
first mammographic reading, 37 lesions (40.2%)
A B
Figure 1. Right breast cancer in a 29-year-old woman who had a palpable lump in the right lower outer quadrant. 
(A) Right mammogram shows no definite mammographic abnormality even in retrospective review. (B) Directed breast
ultrasound reveals an irregular, hypoechoic mass (arrows) with parallel orientation, measuring about 2.16 cm across the
largest diameter, in the lower outer quadrant of the right breast. Histopathology revealed a grade III infiltrating ductal
carcinoma.
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presented, predominantly, as microcalcifications
(Figure 2), 19 lesions (20.6%) showed focal
asymmetry or architectural distortion, 13 lesions
(14.1%) were identified as a mass featuring a sus-
picious finding (Figure 3), 11 lesions (12.0%) had
focal asymmetry or architectural distortion with
microcalcifications, and 11 (12.0%) were identi-
fied as a mass with microcalcifications (Figure 4).
There were 64.2% and 61.6% of TP cancers 
detected at the first and second mammographic
readings, respectively, which presented as micro-
calcifications with or without associated signs
(Table 1).
Of the seven breast cancers that were recognized
only at the second mammographic reading and
that were missed at the first reading, one featured
clustered microcalcifications with a 1-cm dimen-
sion, two revealed focal asymmetry (Figure 5), one
exhibited focal asymmetry with clustered mic-
rocalcifications, two demonstrated architectural
Table 1. Dominant mammographic findings for
the true-positive lesions at the first 
and second mammographic readings*
Finding
First Second 
reading† reading‡
Microcalcifications 37 (40.2) 38 (38.4)
Focal asymmetry or 19 (20.6) 21 (21.2)
architectural distortion
Mass 13 (14.1) 13 (13.2)
Focal asymmetry/architectural 11 (12.0) 12 (12.1)
distortion + microcalcifications
Mass + microcalcifications 11 (12.0) 11 (11.1)
Skin/nipple retraction 1 (1.1) 3 (3.0)
Trabecular thickening 0 (0) 1 (1.0)
Total 92 (100) 99 (100)
*Data are presented as n (%); †prospective reading; ‡retrospective
reading.
Figure 2. Left breast carcinoma in a 39-year-old woman
who felt a huge palpable lump in the left breast. Baseline
left mammogram shows extensive linear, branching and
pleomorphic microcalcifications in the left breast (arrows).
Histopathology revealed an infiltrating ductal carcinoma
measuring 9 cm in size with axillary lymphadenopathies.
Figure 4. Left breast cancer in a 28-year-old woman who
had felt a palpable lump in her left breast for 4 months.
Left mammogram shows an irregular mass associated with
pleomorphic and linear microcalcifications (arrows). The
mass measured 2.5 cm across the largest diameter. Histo-
pathology revealed a grade II infiltrating ductal carcinoma.
Figure 3. Left breast cancer in a 27-year-old woman. Left
mammogram depicts a spiculated mass measuring 2 cm in
size in the left breast (arrow). A grade II infiltrating ductal
carcinoma was diagnosed on histopathology.
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distortion with skin/nipple retraction, and the
remaining one depicted subtle trabecular thicken-
ing (Table 1). Of the 37 lesions presenting as only
microcalcifications at the first mammographic
reading (Table 1), 31 had breast ultrasound avail-
able for correlation and 30 lesions presented as
an evident irregular mass on ultrasound, leaving
one FN lesion missed on ultrasound. The FN case
on ultrasound presented as a cluster of mammo-
graphically visible microcalcifications spanning
about 1 cm at pathology. The second mammo-
graphic reading detected one additional cancer
showing faint clustered punctate microcalcifi-
cations measuring 1 cm on mammography but
2.5 cm at pathology, and the lesion was also de-
picted as a 2-cm mass on ultrasound.
The mean and median sizes of all the 109
pathologically proven lesions at histopathology
were 2.93 ± 1.92 cm and 2.5 cm, respectively. The
mean size of TP lesions at the first and second
readings (measured from mammograms and his-
topathology), and TP and FN lesions at histo-
pathology are summarized in Tables 2 and 3. On
histopathology, the mean size of the mammo-
graphically determined TP lesions was larger than
that of the FN lesions at the first and second read-
ings, but the difference was only statistically signi-
ficant for the second reading (p = 0.004) (Table 3).
Of the 105 study-participating patients, only
four (3.8%) had minimally dense breast paren-
chyma (ACR 2), 68 patients (64.8%) had hetero-
geneously dense breasts (ACR 3), and 33 patients
Table 2. Mean size of the mammographic true-positive lesions at the first and second mammographic readings
with histopathologic correlation*
Mammographic size,† cm Pathologic size,‡ cm p§
First reading (n = 92) 3.22 ± 2.19 3.07 ± 2.01 0.463
Second reading (n = 99) 3.14 ± 2.17 3.05 ± 1.99 0.654
*Data are presented as mean ± standard deviation; †mammographic size of lesions; ‡pathologic size of the mammographic true-positive
lesions; §paired Student’s t test.
A B
Figure 5. Left breast cancer in a 30-year-old woman who had a palpable lump in the 12 o’clock position of her left
breast. (A) Bilateral mammograms (left breast on the right hand side, right breast on the left hand side) reveal a focal
asymmetry (arrow) in the left breast, corresponding to the area of the palpable lump. However, the finding was 
recognized at the second mammographic reading but not identified at the first reading. (B) The corresponding breast 
ultrasound shows a microlobulated hypoechoic mass (arrows) in the 12 o’clock position of the left breast, measuring
1.5 cm across the largest diameter. Histopathology revealed a medullary carcinoma.
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(31.4%) exhibited an extremely dense breast
parenchymal pattern (ACR 4). We detected no
significant difference with regard to breast com-
position distribution between TP and FN lesions
at the first and second mammographic readings
(Table 4).
A total of 90 among the 105 patients had
both mammographic and sonographic examina-
tions available for evaluation and a total of 94
cancerous lesions were diagnosed histopatholog-
ically. Of these 94 lesions, 89 were detected on
ultrasound, such detection featuring a sensitivity of
94.7% and a FN rate of 5.3%. On the other hand,
77 of the 94 corresponding lesions were detected
at the first mammographic reading, such detec-
tion featuring a mammography cancer-detection
sensitivity for these patients of 81.9% and a FN
rate of 18.1%. From the second mammographic
reading of these patients, mammograms were able
to detect 84 of 94 lesions (sensitivity, 89.4%).
Among the other 15 patients without available
breast ultrasonographic examinations for corre-
lation, a total of 15 cancerous lesions were diag-
nosed at histopathology. The pathologic size of
the 15 lesions did not differ significantly from
those of the 94 cancerous lesions from 90 pa-
tients who had both mammograms and ultra-
sound available for correlation (Wilcoxon rank
sum test, p = 0.914, two-tailed). Both the first and
second mammographic readings detected the 
15 lesions, and their dominant mammographic
findings were: microcalcifications (7 lesions), focal
asymmetry with microcalcifications (3), mass with
microcalcifications (2), irregular mass (2), and
architectural distortion (1).
Of the 109 pathologically proven cancers, 76
(69.7%) were classified as infiltrating ductal car-
cinoma (IDC), followed by ductal carcinoma 
in situ (DCIS) (12 lesions, 11.0%), IDC with DCIS
(11 lesions, 10.1%), invasive lobular carcinoma
(ILC) (4 lesions, 3.70%), medullary carcinoma
(2 lesions, 1.83%), mucinous carcinoma (2 le-
sions, 1.83%), IDC and ILC (1 lesion, 0.92%),
and intraductal papillary carcinoma (1 lesion,
0.92%). Of the 17 FN lesions at the first reading,
11 lesions were identified as IDC, followed by
IDC with DCIS (2), ILC (2), medullary carcinoma
(1), and intraductal papillary carcinoma (1). 
Table 4. Distribution of breast composition between mammographic true-positive (TP) and false-negative
(FN) lesions at the first and second mammographic readings
ACR 2,* n (%) ACR 3,† n (%) ACR 4,‡ n (%) p§
First reading 0.455
TP 4 (4.3) 63 (68.5) 25 (27.2)
FN 0 10 (58.8) 7 (41.2)
Second reading 0.283
TP 4 (4.0) 68 (68.7) 27 (27.3)
FN 0 5 (50.0) 5 (50.0)
*ACR 2 is scattered fibroglandular tissue; †ACR 3 is heterogeneously dense breasts; ‡ACR 4 is extremely dense breasts; §Fisher’s 
exact test.
Table 3. Mean pathologic size of mammographic true-positive (TP) and false-negative (FN) lesions at the
first and second mammographic readings*
TP FN
p†
n Size, cm n Size, cm
First reading 92 3.06 ± 2.01 17 2.18 ± 1.05 0.119
Second reading 99 3.03 ± 1.97 10 1.60 ± 0.54 0.004
*Data are presented as mean ± standard deviation; †Wilcoxon rank sum test.
Of the 10 FN lesions at the second reading, seven
were IDC, followed by ILC (2), and medullary
carcinoma (1).
Discussion
Breast cancer occurs rarely among young
women.10,11 Approximately 5.9–7% of breast car-
cinoma occurs before 40 years of age,10,11 and
approximately 2% of breast carcinoma occurs
before the age of 35,4,5 according to reported lit-
erature in Western countries. Breast cancer among
younger-aged women has been reported to pro-
gress at a more rapid rate, and features a poorer
prognosis compared with that for their older
counterparts.11–16 In Asia, the reported incidence
of breast cancer in young Asian women (< 40
years) was 12.6% in Singapore.13 Han et al re-
ported that 12.5% of breast cancers occurred
under 35 years of age in Korea.14 The other series
in our country reported that 29.3% of breast 
cancer patients were diagnosed at the age of 
40 or younger.15 For our hospital, the incidence
of breast cancers diagnosed for women under 
40 years of age constituted 12.9% of the total
number of breast cancer patients; the percentage
is slightly higher than corresponding figures in
Western countries, but relatively similar to the 
results from Asian countries.4,5,10,11,13,14 The rea-
sons for the higher incidence of early-onset breast
cancer in Asian countries are not clear, and may
be investigated from etiologic and epidemiologic
factors.15
A family history of breast cancer tends to
occur more frequently in women with early-onset
breast cancers in some series, compared with
breast cancers that develop later in life, with the
former ranging from 24% to 37%, according to
the reported literature in Western countries.17,18
However, in Asian countries, only 8.7–13% of
women with early-onset breast cancer had a fam-
ily history of breast cancer.15,16 For our study,
8.6% of our patients had a family history of
breast cancer, with this figure appearing to be
much lower than those reported in Western
countries,17,18 but relatively comparable to the
reported series from Asian countries.15,16 Women
with germline mutations of BRCA1 and/or BRCA2
and mutations of other genes may feature an-
other contributor to early-onset breast cancer.16,19
Choi et al reported that the prevalence of BRCA1
and BRCA2 mutations in Korean women with
breast cancer at a young age (≤ 40) was higher
than that in Western countries.16 Therefore, eth-
nicity may be another contributor to early-onset
breast cancer, the influence of such a factor pos-
sibly explaining why a greater incidence of breast
cancer occurs in younger-aged women in Asian
countries compared to their Western counter-
parts. Nevertheless, we did not analyze the possi-
ble germline mutations in our study since no
such detailed clinical data regarding this issue
were available for our study population.
From our study, 24 of 105 (22.8%) patients
were nulliparous and only one patient (1.0%)
was pregnant at the time of cancer diagnosis.
Nulliparity or an advanced maternal age at the
time of the first birth has been reported to be 
a factor in the increased risk of developing breast
cancer in later life.10 However, a considerable
proportion of patients (24 of 105) from our study
delivered their first child before 30 years of age. 
It was also reported that the risk of premeno-
pausal breast cancer is increased in women who
have recently given birth.12 From our study, how-
ever, there was only one example of pregnancy-
associated breast cancer. Therefore, the relationship
between factors of a recent birth or pregnancy
and breast cancer cannot be readily assessed.
Women younger than 40 years of age are not
routinely screened by mammography. Therefore,
it is not surprising that almost all of the patients
in our study had the chief complaints of palpable
lumps. In our study, only one cancer from one
patient was nonpalpable. There were another two
patients with satellite FN cancers missed by mam-
mograms but lying very close to the major TP
cancers, with the FN lesions corresponding to
the same palpable area as the TP findings. We
even encountered delayed diagnoses of breast
cancers for more than 2 years subsequent to the
Breast cancer diagnosis in young women using mammograms in Taiwan
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initial appearance of symptoms of palpable lumps.
The delayed diagnosis was most likely due to non-
belief, since breast carcinoma is rare in younger-
aged women. For younger-aged women exhibiting
related symptoms, it was reported that sonography
is more accurate than mammography for cancer
cancer diagnosis, since the sensitivity of mam-
mography is reduced in younger, denser breasts.8
Ultrasound and diagnostic fine-needle aspiration
are recommended for symptomatic younger-aged
women.10 On the other hand, from our study, the
relative sensitivity of diagnostic mammography
for the detection of breast carcinoma in younger-
aged women is quite acceptable regardless of breast
composition (Table 4). However, since most of
the study participants revealed dense breasts on
mammograms (ACR 3 or 4), and none showed
ACR 1 and only four had ACR 2, we can explain
the results seen in Table 4 as that the sensitivity
of mammography in our study was still accept-
able even in dense breasts, when compared with
other reported series.3,9,20,21 Further, there were
seven patients whose breast carcinomas were di-
agnosed before the age of 30, and there was only
one FN result from mammography in this group.
Clearly, the relative sensitivity of such determi-
nation was acceptable, and it was comparable to
many other reported series.3,9 However, it should
be stressed that the sensitivity and FN rate as re-
vealed by our study were estimated according to
young patients, and the data appeared to differ
from much of that reported previously in the lit-
erature. Previously reported overall FN rates for
mammography have ranged from 8% to 30%,3,9
most of which were based on results obtained
from older asymptomatic screening populations.
Mann et al reported in 1983 that the FN rate for
symptomatic patients in their series was 34.2%.20
However, the other paper has reported a much
lower FN rate of 8.6% for symptomatic patients.21
In fact, the above-mentioned studies focused on
all age groups from Western countries,3,20,21 not
simply on younger-aged women. From the few
available studies focusing on younger-aged women
in Western countries, reported sensitivity ranged
from 69.2% to 86%, with most of the involved
individuals in these studies being symptomatic,4,8
and such a scenario is similar to our study of an
Asian population. The relatively acceptable re-
sults of mammography from our study could be
explained by two factors. First, most of the mam-
mographic TP cancers in our study revealed mi-
crocalcifications with or without other associated
signs (Table 1) on mammograms, and the sign of
microcalcifications can be well recognized even
if the finding is in dense breasts. Second, almost
all (104) of the 105 patients were symptomatic
with only one exception, and the mean pathologic
tumor size of TP cancers on mammograms was
larger than 3 cm in diameter (Tables 2 and 3),
thus causing the lesions to be more easily recog-
nized on mammograms. Our study demonstrated
that 20% and 13.3% of study-participating pa-
tients had experienced symptoms related to breast
cancer for more than 1 and 2 years, respectively.
We cannot presume that mammography could
also have been used effectively to detect these
cancers 1–2 years prior to their actual diagnosis,
at which time the lesions would likely have been
smaller than at the time of actual diagnosis. How-
ever, from our study and other literature,4,5 for
the younger-aged women with symptoms, mam-
mography can provide important information 
in certain situations, such as when searching for
a primary malignancy, aid in characterization of
a suspicious palpable finding and indication of a
biopsy, and further delineation of the extension
of a lesion.
In our study, seven additional cancers were
recognized at the second mammographic reading
with variable mammographic findings (Table 1).
According to the literature, the most common
mammographic findings for FN lesions that failed
to be recognized at the first reading but are de-
picted at retrospective readings are ill-defined
mass, focal asymmetry, or architectural distor-
tion.3,9 Breast cancers showing microcalcifica-
tions were seldom missed by mammography.3,9
In our study, however, there were two of seven
FN lesions missed at the first reading but that were
depicted at the second reading, revealing mam-
mographically visible microcalcifications with or
J. Wang, et al
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without associated sign (Table 1), although mam-
mography is the most reliable imaging tool to
delineate microcalcifications.3 Knowledge of the
possible mammographic findings of FN lesions
can help us interpret mammograms more cau-
tiously and thus reduce the FN rate. Some series
reported the importance of independent double
reading for mammography, which can cause an
increase of up to 15% in the cancer detection
rate.22,23 However, the aforementioned series fo-
cused only on a screening population, instead of
symptomatic women like in our study.
In addition, though there were 40.2% and
38.4% of lesions at the first and second mam-
mographic readings, respectively, presenting only
with the mammographic sign of microcalcifica-
tions (Table 1), most of these lesions can still be
recognized on the corresponding ultrasound as a
mass. The reason for why the sign of a mass was
not depicted on mammograms was most likely
due to the lesions being obscured by superim-
posed, dense breast tissue, resulting in only the
sign of microcalcifications being detected on
mammograms. The reason why the one lesion
showing microcalcifications on mammograms was
missed by ultrasound was most likely because of
its relatively small size.
The actual tumor size at histopathology of
the mammographic TP lesions at the first mam-
mographic reading was somewhat larger than
was the case for the FN lesions, although such
difference did not prove to be significant (Table
3). However, such difference at the second mam-
mographic reading proved to be statistically sig-
nificant (Table 3). Such results appeared to be
compatible with results presented in a number
of studies to the effect that mammographic FN
cancers tend to be smaller than corresponding
TP lesions.3,9
In our study, 90 of 105 study-included patients
had available pre-biopsy mammograms and ul-
trasound results that could be reviewed for com-
parison. Breast ultrasound would appear to have
a higher sensitivity than first and second mam-
mographic readings in these patients. This was
not surprising because the relative sensitivity of
mammography is somewhat reduced for young,
dense breasts.8,20 Further, it has been reported
that ultrasound is a reliable adjunct for younger-
aged, symptomatic patients when mammographic
readings are negative, as mentioned above.8 For
symptomatic patients, negative mammographic
results should not preclude the possibility of
biopsy,20 and ultrasound is strongly recommended
for further evaluation.8 Breast ultrasound is also
a reliable adjunct to mammography in the pre-
operative evaluation of patients with breast can-
cers, especially in dense breasts and when breast
conservation is planned.24 Berg et al reported
that breast ultrasound depicted 15% of multifocal
or multicentric breast cancers in patients suspected
of having unifocal disease by mammograms; in
addition, there were 16 patients in their study
who had multifocal or multicentric cancers diag-
nosed by mammograms, and ultrasound detected
two additional foci in a patient.24 In our study,
ultrasound detected three additional multifocal
cancers than mammograms in two patients.
On the other hand, from our study, there
were 15 cancers from 15 patients without ultra-
sound available for correlation, and all of the 
15 lesions were detected at the first and second
mammographic readings. Though we cannot ob-
tain the ultrasound records for the 15 patients,
and the mammographic findings revealed vari-
able appearances, the actual pathologic tumor size
of the corresponding 15 cancers did not differ
from those of other patients who had ultrasound
available for comparison. Therefore, according
to our result that most TP cancers with mammo-
graphically detected microcalcifications can be
depicted on ultrasound, we might presume that
ultrasound can still feature an acceptable detection
rate for these 15 lesions, even if there were seven
of 15 lesions manifesting as only microcalcifica-
tions on mammograms.
For the purposes of our study, we did not fur-
ther investigate the pathology types of breast car-
cinoma suffered by these younger-aged women,
since most of the patients in our study presented
with a pathology type of IDC, a condition quite
similar to their older counterparts.
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Early detection of breast cancer may be an
important issue for the sake of enhancing the life
expectancy of women suffering from breast can-
cer at a relatively younger age. Though mammog-
raphy is the standard modality for breast cancer
screening, its relative sensitivity is somewhat poorer
for younger dense breasts than for older, fatty
breasts, as has been mentioned above.5,20 It was
reported that screening breast sonography could
detect more occult breast cancers that are not 
detected on mammography or physical exami-
nation, and such a benefit is especially obvious
among women with dense breasts and increased
risk of breast cancer.25–27 However, because most
of the younger-aged patients in our study did not
have a family history of breast cancer, and most
of them were symptomatic at the time of pre-
sentation, we cannot presume that these young
women without obvious risk of breast cancer
would have benefited from ultrasound screening
if they had undergone ultrasound screening long
before their cancers had become symptomatic.
Breast magnetic resonance imaging (MRI) is
another possible option for breast cancer screen-
ing for young women.2,28 Breast MRI has a high
sensitivity for the detection of invasive breast
cancer,2,6 but the published results regarding breast
MRI detection for in situ disease vary widely, with
the sensitivity for detecting DCIS ranging from
40% to 100%.2 Most previous breast MRI screening
programs enrolled only women who had a posi-
tive family history of breast cancer and/or certain
breast cancer-related germline mutations.6,28 How-
ever, most women participating in our series fea-
tured neither a family history of breast cancer
nor any available germline-mutation results. It is
thus problematic with regard to whether MRI is
suitable for routine breast cancer screening for
younger-aged women without a family history of
breast cancer.
In conclusion, from our study in Taiwan,
12.9% of women with breast cancer had their
cancer diagnosed before the age of 40 years.
Mammography has an acceptable sensitivity rate
for the detection of breast cancer among women
younger than 40 years of age, most of whom
show dense breasts on mammograms and pres-
ent with symptoms of palpable lumps, and most
of whom feature signs of mammographically vis-
ible microcalcifications, and which therefore de-
fine mammography’s impressive diagnostic value
even in dense breasts. Breast ultrasonography can
offer a slightly higher sensitivity than mammog-
raphy for the detection of breast cancer for such
a population.
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